https://www.selleckchem.com/pr....oducts/Pyroxamide(NS
The participants of both groups were similar in terms of demographic, clinical, and baseline laboratory characteristics. Four patients (9.3%) presented with warfarin-induced hematoma, among which the warfarin administration stopped for 5.33±1.44days and then restarted again. None of the patients was forced to cease warfarin therapy because of significant hemorrhages. The mean duration of catheter functioning was 8.30±1.75months in the intervention group versus 3.90±1.12months in the controls (P-value0.001). Based on t
Like
Comment
Share
